Home ›
Trademark Categories ›
Pharmaceuticals ›
2000 ›
EX ›
EXPOCIDE
Trademark search for:
EXPOCIDE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2000-11-28 — Application filed
2001-04-23 — Assigned to examiner
2001-04-24 — Examiner's amendment mailed
2001-05-01 — Examiner's amendment mailed
2001-05-02 — Approved for pub - principal register
2001-08-01 — Notice of publication
2001-08-21 — Published for opposition
2001-11-13 — Noa mailed - sou required from applicant
2002-03-26 — Sou teas extension received
2002-03-27 — Sou extension 1 filed
2002-04-02 — Sou extension 1 granted
2002-10-17 — Sou teas extension received
2002-10-17 — Sou extension 2 filed
2002-11-06 — Sou extension 2 granted
2003-03-28 — Sou teas extension received
2003-03-28 — Sou extension 3 filed
2003-05-14 — Sou extension 3 granted
2003-09-24 — Sou teas extension received
2003-09-24 — Sou extension 4 filed
2003-10-06 — Sou extension 4 granted
2004-04-05 — Sou teas extension received
2004-04-05 — Sou extension 5 filed
2004-04-14 — Sou extension 5 granted
2004-04-14 — Case file in ticrs
2004-04-29 — Teas change of correspondence received
2004-11-14 — Final status recorded
2005-03-10 — Application abandoned
2005-03-10 — Application abandoned
Owner Information
Bristol-Myers Squibb Company
New York , NY
Bristol-Myers Squibb Company
New York , NY
Correspondent
NADINE P FLYNN BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVE TRADEMARK DEPT NEW YORK, NY 10154-0004
Filing Details
Filing Date:
2000-11-28
Status Date:
2004-11-14
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.